Effect of fusion protein cleavage site sequence on generation of a genotype VII newcastle disease virus vaccine

PLoS ONE

Volumn 13, Issue 5, 2018, Pages

  Manoharan, Vinoth K ^a   Varghese, Berin P ^a   Paldurai, Anandan ^a   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSION PROTEIN; NEUTRALIZING ANTIBODY; NEWCASTLE DISEASE VACCINE; LIVE VACCINE; VIRUS ANTIBODY; VIRUS FUSION PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL FUSION; CHICKEN; CONTROLLED STUDY; EMBRYO; FUSION PROTEIN CLEAVAGE SITE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNIZATION; MUTAGENESIS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; NONHUMAN; PROTEIN CLEAVAGE; VIRUS SHEDDING; VIRUS STRAIN; ANIMAL; BIRD DISEASE; CELL LINE; CHICK EMBRYO; GENETICS; IMMUNOLOGY; MUTATION; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHICK EMBRYO; CHICKENS; HUMANS; MUTATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VACCINATION; VACCINES, ATTENUATED; VIRAL FUSION PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 85046972220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0197253     Document Type: Article

References (29)

1. Alexander DJ. Newcastle disease and other avian Paramyxoviridae infection. In: Calnek BW, editor. Diseases of Poultry. 10 ed: Ames,Iowa: Iowa State University Press; 1997. p. 541–69.
2. Samal SK. Newcastle Disease and related avian paramyxoviruses. In: Samal SK, editor. The Biology of Paramyxoviruses Caister Academic Press, Norfolk, UK.; 2011. p. 69–114.
3. Alexander DJ. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech. 2000; 19(2):443–62. Epub 2000/08/10. PMID: 10935273
4. Manoharan VK, Khattar SK, Paldurai A, Kim SH, Samal SK. A Y527A mutation in the fusion protein of Newcastle disease virus strain LaSota leads to a hyperfusogenic virus with increased replication and immunogenicity. The Journal of general virology. 2016; 97(2):287–92. Epub 2015/11/21. https://doi.org/10.1099/jgv.0.000350 PMID: 26586083
5. Kim SH, Wanasen N, Paldurai A, Xiao S, Collins PL, Samal SK. Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine. PloS one. 2013; 8 (8).
6. Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microbial pathogenesis. 2004; 36(1):1–10. Epub 2003/12/04. PMID: 14643634
7. Susta L, Jones ME, Cattoli G, Cardenas-Garcia S, Miller PJ, Brown CC, et al. Pathologic characterization of genotypes XIV and XVII Newcastle disease viruses and efficacy of classical vaccination on specific pathogen-free birds. Veterinary pathology. 2015; 52(1):120–31. Epub 2014/02/11. https://doi.org/10.1177/0300985814521247 PMID: 24510948
8. Tirumurugaan KG, Kapgate S, Vinupriya MK, Vijayarani K, Kumanan K, Elankumaran S. Genotypic and pathotypic characterization of Newcastle disease viruses from India. PloS one. 2011; 6(12):e28414. Epub 2011/12/17. https://doi.org/10.1371/journal.pone.0028414 PMID: 22174801
9. Abolnik C, Horner RF, Bisschop SP, Parker ME, Romito M, Viljoen GJ. A phylogenetic study of South African Newcastle disease virus strains isolated between 1990 and 2002 suggests epidemiological origins in the Far East. Archives of virology. 2004; 149(3):603–19. Epub 2004/03/03. https://doi.org/10.1007/s00705-003-0218-2 PMID: 14991446
10. Herczeg J, Wehmann E, Bragg RR, Travassos Dias PM, Hadjiev G, Werner O, et al. Two novel genetic groups (VIIb and VIII) responsible for recent Newcastle disease outbreaks in Southern Africa, one (VIIb) of which reached Southern Europe. Archives of virology. 1999; 144(11):2087–99. Epub 1999/12/ 22. PMID: 10603164
11. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB. Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985–2001. Archives of virology. 2003; 148(7):1387–403. Epub 2003/06/27. https://doi.org/10.1007/s00705-003-0014-z PMID: 12827467
12. Diel DG, da Silva LH, Liu H, Wang Z, Miller PJ, Afonso CL. Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2012; 12(8):1770–9. Epub 2012/08/16. https://doi.org/10.1016/j.meegid.2012.07. 012 PMID: 22892200
13. Jeon WJ, Lee EK, Lee YJ, Jeong OM, Kim YJ, Kwon JH, et al. Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. Journal of veterinary science. 2008; 9(3):295–300. Epub 2008/08/22. https://doi.org/10.4142/jvs.2008.9.3.295PMID: 18716450
14. Rui Z, Juan P, Jingliang S, Jixun Z, Xiaoting W, Shouping Z, et al. Phylogenetic characterization of Newcastle disease virus isolated in the mainland of China during 2001–2009. Veterinary microbiology. 2010; 141(3–4):246–57. Epub 2009/10/17. https://doi.org/10.1016/j.vetmic.2009.09.020 PMID: 19833457
15. Hu S, Ma H, Wu Y, Liu W, Wang X, Liu Y, et al. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine. 2009; 27(6):904–10. Epub 2008/12/20. https://doi.org/10.1016/j.vaccine.2008.11.091 PMID: 19095026
16. Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, Prajitno TY, et al. Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain. PloS one. 2012; 7(12).
17. Miller PJ, Afonso CL, El Attrache J, Dorsey KM, Courtney SC, Guo Z, et al. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Developmental and comparative immunology. 2013; 41(4):505–13. Epub 2013/06/26. https://doi.org/10.1016/j.dci.2013.06.007 PMID: 23796788
18. Scheid A, Choppin PW. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 1977; 80(1):54–66. Epub 1977/07/01. PMID: 195398
19. Kim SH, Chen Z, Yoshida A, Paldurai A, Xiao S, Samal SK. Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines. PloS one. 2017; 12(3): e0173965. Epub 2017/03/25. https://doi.org/10.1371/journal.pone.0173965 PMID: 28339499
20. Huang ZH, Krishnamurthy S, Panda A, Samal SK. High-level expression of a foreign gene from the most 3’-proximal locus of a recombinant Newcastle disease virus. Journal of General Virology. 2001; 82:1729–36. https://doi.org/10.1099/0022-1317-82-7-1729 PMID: 11413385
21. OIE. Terrestrial Manual. Paris: World Organization for Animal Health; 2009.
22. Xiao S, Khattar SK, Subbiah M, Collins PL, Samal SK. Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens. Journal of virology. 2012; 86 (7):3828–38. Epub 2012/01/20. https://doi.org/10.1128/JVI.06765-11 PMID: 22258248
23. Reed L J, Muench H. A simple method of estimating fifty per cent endpoints. The american journal of hygiene. 1938(27):493–7.
24. Hu Z, Hu S, Meng C, Wang X, Zhu J, Liu X. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs. Avian diseases. 2011; 55(3):391–7. Epub 2011/10/25. https://doi.org/10.1637/9633-122410-Reg.1 PMID: 22017036
25. Liu MM, Cheng JL, Yu XH, Qin ZM, Tian FL, Zhang GZ. Generation by reverse genetics of an effective attenuated Newcastle disease virus vaccine based on a prevalent highly virulent Chinese strain. Biotechnology letters. 2015; 37(6):1287–96. Epub 2015/03/01. https://doi.org/10.1007/s10529-015-1799-zPMID: 25724719
26. Miller PJ, Estevez C, Yu Q, Suarez DL, King DJ. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian diseases. 2009; 53(1):39–49. Epub 2009/05/13. https://doi.org/10.1637/8407-071208Reg.1 PMID: 19432002
27. Roohani K, Tan SW, Yeap SK, Ideris A, Bejo MH, Omar AR. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV. Journal of veterinary science. 2015; 16(4):447–57. Epub 2015/02/04. https://doi.org/10.4142/jvs.2015.16.4.447 PMID: 25643805
28. Cardenas-Garcia S, Diel DG, Susta L, Lucio-Decanini E, Yu Q, Brown CC, et al. Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologi-cals: journal of the International Association of Biological Standardization. 2015; 43(2):136–45. Epub 2014/12/17.
29. Miller PJ, King DJ, Afonso CL, Suarez DL. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine. 2007; 25(41):7238–46. Epub 2007/08/28. https://doi.org/10.1016/j.vaccine.2007.07.017 PMID: 17719150